|
Validation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
|
National Institutes of Health |
October 2, 2026
|
$2M |
Nonprofits
|
|
Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
|
National Institutes of Health |
October 2, 2026
|
— |
Nonprofits
|
|
Logistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
|
National Institutes of Health |
October 2, 2026
|
$575k |
Nonprofits
|
|
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
|
National Institutes of Health |
October 3, 2026
|
— |
Nonprofits
|
|
Advancing Research on the Application of Digital Health Technology to the Management of Type 2 Diabetes (R01- Clinical Trail Required)
|
National Institutes of Health |
October 6, 2026
|
— |
Nonprofits
|
|
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
|
National Institutes of Health |
October 9, 2026
|
$1M |
Nonprofits
|
|
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 9, 2026
|
$300k |
Nonprofits
|
|
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 9, 2026
|
— |
Nonprofits
|
|
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
|
National Institutes of Health |
October 11, 2026
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
$250k |
Nonprofits
|
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 14, 2026
|
— |
Nonprofits
|
|
Advancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
|
National Institutes of Health |
October 15, 2026
|
— |
Nonprofits
|
|
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed)
|
National Institutes of Health |
October 15, 2026
|
— |
Nonprofits
|
|
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
October 16, 2026
|
$300k |
Nonprofits
|
|
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2026
|
$600k |
Nonprofits
|
|
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2026
|
$600k |
Nonprofits
|
|
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed)
|
National Institutes of Health |
October 19, 2026
|
— |
Nonprofits
|
|
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2026
|
$50k |
Nonprofits
|
|
PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2026
|
— |
Nonprofits
|
|
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
|
National Institutes of Health |
October 19, 2026
|
— |
Nonprofits
|
|
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
|
National Institutes of Health |
October 20, 2026
|
$750k |
Nonprofits
|
|
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
|
National Institutes of Health |
October 22, 2026
|
— |
Nonprofits
|
|
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
|
National Institutes of Health |
October 30, 2026
|
$500k |
Nonprofits
|
|
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
|
National Institutes of Health |
October 30, 2026
|
$2.2M |
Nonprofits
|
|
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
|
National Institutes of Health |
October 30, 2026
|
$1.2M |
Nonprofits
|
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
|
National Institutes of Health |
October 30, 2026
|
— |
Nonprofits
|
|
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
|
National Institutes of Health |
November 2, 2026
|
— |
Nonprofits
|
|
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 2, 2026
|
— |
Nonprofits
|
|
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 5, 2026
|
— |
Nonprofits
|
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 6, 2026
|
$350k |
Nonprofits
|
|
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
|
National Institutes of Health |
November 10, 2026
|
— |
Nonprofits
|
|
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 10, 2026
|
$300k |
Nonprofits
|
|
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
|
National Institutes of Health |
November 10, 2026
|
$150k |
Nonprofits
|
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
|
National Institutes of Health |
November 13, 2026
|
$1.1M |
Nonprofits
|
|
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
|
National Institutes of Health |
November 13, 2026
|
$350k |
Nonprofits
|
|
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
|
National Institutes of Health |
November 13, 2026
|
— |
Nonprofits
|
|
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
|
National Institutes of Health |
November 13, 2026
|
$750k |
Nonprofits
|
|
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
|
National Institutes of Health |
November 16, 2026
|
$50k |
Nonprofits
|
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
|
National Institutes of Health |
November 17, 2026
|
$200k |
Nonprofits
|
|
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
|
National Institutes of Health |
November 17, 2026
|
$350k |
Nonprofits
|
|
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
|
National Institutes of Health |
November 17, 2026
|
— |
Nonprofits
|
|
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
|
National Institutes of Health |
November 17, 2026
|
— |
Nonprofits
|
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
|
National Institutes of Health |
November 17, 2026
|
— |
Nonprofits
|
|
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
|
National Institutes of Health |
November 18, 2026
|
— |
Nonprofits
|
|
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
|
National Institutes of Health |
November 18, 2026
|
— |
Nonprofits
|
|
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional)
|
National Institutes of Health |
November 19, 2026
|
— |
Nonprofits
|
|
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
|
National Institutes of Health |
November 19, 2026
|
— |
Nonprofits
|